Literature DB >> 25464054

Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology.

Angelique F Showman1, Jonathan D Baker2, Christina Linares3, Chrystie K Naeole3, Robert Borris4, Edward Johnston5, Jerry Konanui5, Helen Turner6.   

Abstract

In 2010, a National Science Foundation project in Hawai`i assembled a collaboration of Pacific indigenous scientists, Hawaiian cultural practitioners and scientists trained in Western pharmacology. The objective of the collaborative project was to study Kava, a culturally significant Pacific beverage, and to address and ultimately transcend, long-standing barriers to communication and collaboration between these groups. Kava is a product of the `awa plant (Piper methysticum) that has been used ceremonially and medicinally throughout the history of Pacific Island cultures, and is now in widespread recreational and nutraceutical use in the US. This project, culminating in 2015, has enriched the participants, led to published work that integrates cultural and Western pharmacologic perspectives and established a paradigm for collaboration. This review paper integrates cultural and Western perspectives on efficacy, toxicity and the future cultural and commercial significance of `awa in the Pacific. Here we present a detailed review of traditional and non-traditional kava usage, medicinal efficacy and potential toxicological concerns. Recent mechanistic data on physiological action and potential pathological reactions are evaluated and interpreted.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Kava; Kavalactones; Piper methysticum

Mesh:

Substances:

Year:  2014        PMID: 25464054     DOI: 10.1016/j.fitote.2014.11.012

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  7 in total

1.  Protective effect of kava constituents in an in vitro model of oral mucositis.

Authors:  Callisthenis Yiannis; Kevin Huang; An Nhien Tran; Cathy Zeng; Emily Dao; Oliver Baselyous; Muaaz Adil Mithwani; Rita Paolini; Nicola Cirillo; Tami Yap; Michael McCullough; Antonio Celentano
Journal:  J Cancer Res Clin Oncol       Date:  2020-05-20       Impact factor: 4.553

2.  In vivo Structure-Activity Relationship of Dihydromethysticin in Reducing Nicotine-Derived Nitrosamine Ketone (NNK)-Induced Lung DNA Damage against Lung Carcinogenesis in A/J Mice.

Authors:  Santanu Hati; Qi Hu; Zhiguang Huo; Junxuan Lu; Chengguo Xing
Journal:  ChemMedChem       Date:  2022-03-04       Impact factor: 3.540

Review 3.  Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.

Authors:  Flaminia Pantano; Roberta Tittarelli; Giulio Mannocchi; Simona Zaami; Serafino Ricci; Raffaele Giorgetti; Daniela Terranova; Francesco P Busardò; Enrico Marinelli
Journal:  Int J Mol Sci       Date:  2016-04-16       Impact factor: 5.923

Review 4.  An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava.

Authors:  Rita B Soares; Ricardo Jorge Dinis-Oliveira; Nuno G Oliveira
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

5.  Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.

Authors:  Han Chow Chua; Emilie T H Christensen; Kirsten Hoestgaard-Jensen; Leonny Y Hartiadi; Iqbal Ramzan; Anders A Jensen; Nathan L Absalom; Mary Chebib
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

Review 6.  Kava as a Clinical Nutrient: Promises and Challenges.

Authors:  Tengfei Bian; Pedro Corral; Yuzhi Wang; Jordy Botello; Rick Kingston; Tyler Daniels; Ramzi G Salloum; Edward Johnston; Zhiguang Huo; Junxuan Lu; Andrew C Liu; Chengguo Xing
Journal:  Nutrients       Date:  2020-10-05       Impact factor: 5.717

Review 7.  Medicine in motion: Opportunities, challenges and data analytics-based solutions for traditional medicine integration into western medical practice.

Authors:  C Jansen; J D Baker; E Kodaira; L Ang; A J Bacani; J T Aldan; L M N Shimoda; M Salameh; A L Small-Howard; A J Stokes; H Turner; C N Adra
Journal:  J Ethnopharmacol       Date:  2020-10-21       Impact factor: 4.360

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.